S Saeki - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S Saeki

Showing results (221-230 of 223) with videos related to

Pageof 23

Sort By:

You have reached the last page of results.This site can display upto 223 results.

ESMO Open|July 8, 2022

Corrigendum to 'Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study': [ESMO Open Volume 6, Issue 4, August 2021, 100191]K Hotta, S Saeki, M Yamaguchi, et al.

ESMO Open|June 21, 2021

Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II studyK Hotta, S Saeki, M Yamaguchi, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2017

Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibodyY Tomita, D Sueta, Y Kakiuchi, et al.

Pageof 23

Search research articles

Showing results (221-230 of 223) with videos related to

Sort By:

Pageof 23

You have reached the last page of results.This site can display upto 223 results.

ESMO Open|July 8, 2022

ESMO Open|June 21, 2021

Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II studyK Hotta, S Saeki, M Yamaguchi, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2017

Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibodyY Tomita, D Sueta, Y Kakiuchi, et al.

Pageof 23